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ABSTRACT 
 
Medical imaging now plays an integral role in the diagnosis and treatment of illness. The use of 
contrast agents in molecular imaging has been instrumental in the diagnosis of cancer and similar 
pathologies. The incorporation of lanthanide-based contrast agents employed in magnetic 
resonance imaging (MRI) into nano-assembled capsules (NACs) have shown potential utility for 
improved contrast in MRI by slowing the tumbling of the polyanionic paramagnetic metal ions. 
The utility of NACs was herein extended to computed tomography (CT) imaging by the 
incorporation of electron dense bismuth (III)-based chelates into NACs in order to provide a high 
payload of agent in relatively small volumes. Bismuth (III) was chelated with 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetramethylene phosphonate (DOTP) and incorporated into a 
NAC encapsulated with a spherical silica nanoparticle shell at varied concentrations, solvent 
systems and temperature. The size distribution of these NACs was characterized and compared to 
gadolinium-based NACs. The formation of bismuth containing NACs was confirmed; the 
reproducibility in size distribution was not as reproducible as expected, and did not adhere to the 
same trends as lanthanide containing capsules. Although aging time may be directly related to size 
distribution of the capsules, the solvent system and temperature studies did not yield a consistent 
relationship. 
 
INTRODUCTION 
 
The importance of inflammation in the progression of cancer and cardiovascular disease has 
recently become apparent.1 The ability to monitor how inflammation progresses in vivo may 
provide a more complete understanding of the development and treatment of these diseases. In 
order to accomplish this, it is necessary to employ methodologies that allow the different stages of 
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inflammation to be mapped. For practices such as magnetic resonance imaging (MRI), 
lanthanide(III) ion-based CAs have been shown to provide optimal effects on the relaxation rates 
of water protons in order to differentiate between tissues and aid in more meaningful diagnostics. 
However, lanthanide ions, such as gadolinium(III), are toxic in vivo and must therefore be 
chemically altered in order to be clinically useful.2 The advantage chelates offer for the 
modification of xenobiotic metal ions in MRI are twofold: a reduction in toxicity and the 
possibility of an increase in relaxivity to provide superior contrast. A main aim in the development 
of contrast agents (CAs) is to design structures specifically to differentiate various inflammation 
types, which are characterized by the localization of macrophages that can conveniently be 
targeted with nano-scale particulate agents that are then endocytosed.3 Thus, the design of chelates 
suitable for the coordination of lanthanide ions has become a prevalent field of study, seated at a 
junction between inorganic coordination chemistry and organic synthesis in an overarching aim to 
diagnose and treat cancer.  
Clinical contrast agents (CAs) for computed tomography (CT) imaging include high atomic 
number (Z) ions as X-ray attenuating agents; clinically they are largely comprised of small 
iodinated molecules such as iopamidol, iohexol and iodixanol.4 Although iodine is relatively 
electron dense and effective in X-ray attenuation, current CAs have limited utility in their capacity 
to target tissues.5 Bismuth nanoparticles (Bi-NPs) have become an increasingly attractive 
candidate for CT contrast agents due to low toxicity, high electron density, stability and surface 
modification capability.6,7 Synthesis of the nanoparticles published typically range from 30 to 80 
nm in size, formed largely by the pH dependent reduction of bismuth(III) cations. 
The comparison of two bismuth-based nano-systems with a potential utility in computed 
tomography imaging was herein investigated: dense and compact bismuth nanoparticles and Bi3+ 
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containing nano-assembled capsules similar to those that have been developed to enhance MRI 
contrast agents by slowing the anionic tumbling of lanthanide-based CAs.8 The NAC model has 
been of interest due to the ability to deliver a large payload of agent in small doses with surface 
modification potential. The synthetic protocol for lanthanide containing NACs has been adapted 
to determine whether NAC formation is possible for the incorporation of electron dense, 
diamagnetic Bi3+ complexes to provide a comparison of contrast efficacy of capsules versus 
nanoparticles. 
 
Figure 1. A schematic representation of the preparation of BiDOTP5- containing, SiO2-NP coated NACs. 
The nano-encapsulation process first involves synthesizing a polyanionic metal complex. Then, as 
shown in Figure 1, an aggregate of the chelate with a cationic polymer, in this case polyallylamine 
hydrochloride (PAH), is formed and encapsulated by a silica nanoparticle shell. The average size 
of gadolinium-based NACs was found to increase proportionally with the ratio of the concentration 
of charges on the anionic complex and cationic polymer; a term expressed as the R value (Eqn 1). 
 
     𝑅 =
[𝑐ℎ𝑒𝑙𝑎𝑡𝑒] × 𝑍−
[𝑝𝑜𝑙𝑦𝑚𝑒𝑟] × 𝑍+
     (1) 
 
As the value of R was increase from 0.3 to 1.25 for Gd-DOTP5- and Gd-TTHA3- based NACs 
prepared in a solvent system of 3:2 v/v acetonitrile/water the capsule size increased 
correspondingly.9 Bismuth complexes of the same ligands (DOTP and TTHA) were anticipated to 
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facilitate capsule formation in much the same way as the Gd3+ chelates and to exhibit a similar 
trend in the relationship between the R value to the size of particle in a similar solvent system.  
 
Figure 2.  Structures of ligands investigated in this report. 
Fig. 2 shows the ligands used to complex Bi3+ to conduct size comparisons of capsules with 
previously reported lanthanide NACs. The formation of these BiTTHA3- and BiDOTP5- and their 
synthetic protocols have been previously published.10,11  However, the BiTTHA3- complex when 
synthesized was found to be insoluble in water and therefore could not be utilized in this study. 
BiDOTP5- was employed to test the feasibility of preparing Bi3+ containing NACs and for size 
comparison experiments. DOTP is known to form a stable, soluble anionic complex with the 
trivalent ion of interest, Bi3+. The size comparison study was extended to include various solvent 
systems including various solvents, R values, temperatures and aging times involved in the 
aggregate formation of polymer and complex. 
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METHODS 
Reagents and Solvents 
All water used in synthesis and instrumental testing was deionized water with a resistivity of 18.2 
MΩ. H6TTHA, PAH and Bi2O3 were purchased from the Sigma-Aldrich corporation. The 
molecular weight quoted by Sigma-Aldrich (St Louis, MO, USA) of the PAH used in this study is 
56,000, not as previously reported by the manufacturer 70,000. H8DOTP was purchased from 
Macrocyclics (Dallas, TX, USA). Silica nanoparticles Snowtex O-type were purchased from 
Nissan Chemicals USA (Houston, TX, USA) as a 20.2 w/w suspension in water (pH 3.5). 
 
Bi-DOTP Synthesis 
The synthesis of Bi3+ DOTP complexes was carried out by the addition of Bi2O3 at pH 0 in nitric 
acid portion wise to a solution of H8DOTP at pH = 4 - 5 with heating.  The progress of the chelation 
reaction was then monitored by potassium iodide tests to indicate whether any free bismuth was 
left in solution. If any free ion was detected, more ligand was added. Once all bismuth was 
complexed, the solution was freeze-dried to remove solvent. The resulting powder was weighed 
and dissolved in a small amount of water to create a stock solution from which all experiments 
were conducted. 
 
NAC Preparation 
A 8.9 μM stock solution of PAH was prepared by dissolving PAH (0.0498 g, 0.89 μmol) in a 
mixture correspondent to the solvent system being analyzed (10 mL). The pH of the chelate stock 
solution was adjusted to 9 by NaOH. A stock 2% suspension of SNPs was prepared by adding 1 
mL of a commercially available 20.2 wt% suspension of SNPs in water to 9 mL of MeCN. Upon 
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addition of the chelate stock solution the reaction became turbid indicating the formation of an 
aggregate. Aggregates were aged for 10 minutes before addition of the 2% SNP stock solution 
(100 μL). The reaction was vortexed for a further 10 seconds at medium speed and then allowed 
to age without agitation for 30 minutes. Excess SNPs were removed by filter centrifugation using 
10 kDa MWCO filter centrifuge tube at 6,000 rpm. The NACs retained in the filter centrifuged 
tube were washed with water and filtered by centrifugation for 30 minutes at 14,000 rpm a total of 
six times. The NACs were then taken up into water (1 mL) and recovered into a sample vial. 
 
Microscopy 
Scanning electron microscopy (SEM) was performed on a FEI (Hillsboro, OR, USA) Sirion FEG 
electron microscope equipped with an energy dispersive X-ray (EDX) detector. A droplet of NACs 
suspension was placed on the aluminium stub and dried in air. The sample was then sputter coated 
with gold for 55 seconds. Secondary electron images were taken at 5 kV with a working distance 
between 5-10 mm. 
 
Dynamic Light Scattering 
Dynamic light scattering was performed on a Horiba (Irvine, CA, USA) LB-550 dynamic light 
scattering instrument. For these measurements freshly syringe filtered samples were dispersed in 
water and measured at four dilutions to ensure size distributions were independent of concentration 
effects. Samples were regularly agitated to guard against settling of larger particles. 
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RESULTS/DISCUSSION 
 
Initial preparations of NACs containing BiDOTP5- were attempted employing the most successful 
reaction conditions from the preparation of Gd3+ containing NACs9: 3:2 v/v MeCN and H2O as 
solvent at pH 9.  The formation of capsules was confirmed by electron microscopy (Figure 3) 
which shows spherical particles were produced in the reaction. The images also suggest chemical 
debris was not completely removed and more extensive centrifugation and cleaning should be used 
in order to remove all excess polymer. Significantly, the SEM images show similar polydispersity 
in the BiDOTP5- containing NACs that was observed under the same conditions for the Gd-based 
NACs, although reproducibility was largely variable and often formed statistically different sized 
populations of NACs under the same conditions. Dynamic light scattering techniques depicted in 
Fig. 4 were consistent with the polydispersity shown in the SEM images. 
  
 
Figure 3. SEM images of BiDOTP NACs formed in 3:2 v/v MeCN/water under room 
temperature conditions with 10 minute aging. 
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To determine whether Bi-DOTP interacted similarly with the PAH polymer as Gd-DOTP, the R 
value of Bi-DOTP NACs was varied to conclude whether the linear relationship with size 
distribution exists for the novel NACs in comparison to Gd-NACs, displayed in Fig. 4. 
.  
 
Figure 4. a) Chart of average size distributions in Bi-DOTP and Gd-DOTP NACs formed with 3:2 v/v MeCN/water 
under room temperature conditions and 10 minute aging. Error bars indicate the averaged standard deviation 
of the distribution population. b) Average size distributions over each synthetic attempt of Bi-NACs formed with 3:2 
v/v MeCN/water under room temperature conditions and 10 minute aging. 
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BiDOTP NACs did not appear to follow the same linear relationship in size distribution with an 
increase in R value as those previously reported for Gd-based NACs. Fig. 4 depicted size 
distributions for Bi-NACs that were smaller and did not follow a linear trend, coupled with their 
irreproducibility, although data showed a slight Gaussian trend with a mean occurring at R = 0.75. 
In order to attempt manipulation of the size of the NACs, solvent systems of 1:1 v/v MeCN/water 
and 1:1 v/v EtOH/water were attempted at temperatures ranging from 0˚C to ambient with aging 
times between 1 and 10 minutes.  
 
Figure 5. Average size distributions of Bi-NACs formed with a solvent system of 1:1 v/v MeCN/water at 
ambient temperature with varied aging times. Error bars indicate the averaged standard deviation of 
the distribution population. 
 
Fig. 5 showed an apparent linear trend with increased aging times and suggested that size 
manipulation for these conditions may be possible by a function of how long complex interacts 
with the polymer. However, the size distributions of these NACs were almost 5 times larger than 
those formed with 3:2 v/v MeCN/water solvent systems and were too large for a reasonable 
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comparison to the average sizes of Bi-NPs, which are typically 30-80 nm in diameter. Temperature 
was reduced during synthesis in further experiments to establish whether a decrease in kinetic 
energy would allow for smaller NAC formation. 
 
Figure 6. a) Average size distributions of Bi-NACs with R = 0.75 formed with a solvent system of 1:1 v/v 
MeCN/water at varied temperature and aging times. b) Average size distributions of Bi-NACs formed with a solvent 
system of 1:1 v/v EtOH/water at varied temperature and aging times. Error bars indicate the averaged standard 
deviation of the distribution population. 
 
When the temperature was decreased to 0˚C, there was not a decrease in the size distribution of 
the particles as expected, with the exception of aging times 3 and 5 minutes in 1:1 v/v MeCN/water 
solvent system. Generally, the average size of capsule tended to increase with a decrease in 
temperature in the EtOH/water solvent system and the magnitude of the sizes remained too large 
for a viable comparison with Bi-NPs.  
In conclusion, the formation of NACs containing Bi-DOTP complexes was confirmed. However, 
the size distribution of the particles was highly inconsistent. As a result the contrast efficacy was 
not established. Moving forward, further research should focus on additional chelates to determine 
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whether the size distributions are consistent in bismuth-based NACs in an effort to interpret the 
disparity in the ability of bismuth complexes to interact with the polymers in a similar manner as 
Gd-based counterparts. Furthermore, varied cationic polymers could also be studied to determine 
whether PAH is unique in its interactions with Bi-DOTP. Flow cytometry studies could potentially 
be utilized to compare contrast on a per-NAC basis with Bi-NPs of similar size.  
 
CONCLUSIONS 
 
Bismuth was complexed with DOTP to investigate the feasibility to form bismuth-based NACs in 
order to assess their contrast efficacy relative to bismuth nanoparticles for CT imaging. However, 
upon their formation, it was evident that the irreproducible nature of size distributions in bismuth-
based NACs did not allow for a meaningful comparison. Thus, varied experimental conditions 
were investigated in an effort to control for the size dispersity of the Bi-NACs. However, varied 
solvent systems, synthesis temperature and aging time did not prove to have a significant effect on 
their size distribution. 
Further studies in this work will focus on a method to separate the particles into more narrow size 
distributions. Once this is accomplished and a method of comparing Bi-NACs with Bi-NPs on a 
per-particle basis is established, series of phantoms containing Bi-NACs and Bi-NPs at different 
concentrations should be imaged to assess the effects on particle size and Bi3+ density on the ability 
to generate contrast in CT images. These experiments would allow for the identification of the 
agents suitable for CT contrast agents and once complete could lead to the modification of the 
particle synthesis to ensure adequate stability (and possible functionalization) necessary. 
Additional work could begin to examine how different genotypes of macrophage respond to each 
different nano-particle. In particular, the investigation into the extent to which one nano-particle 
may be favored for endocytosis by one genotype over another. 
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